Neurotrope Inc.

(NTRP) Trade

By |

Profile

Neurotrope Inc is a biopharmaceutical company. The company is principally focused on developing a product platform based on a drug candidate called bryostatin for the treatment of Alzheimer's disease ("AD"), which is in the clinical testing stage. It is also developing bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C, which are in pre-clinical testing.

Contact Information

Website: www.neurotrope.com
Email: rweinstein@neurotrope.com
Main Phone: +1 973 242-0005
Address: 1185 Avenue of the Americas
Address 2: 3rd Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10036

Issuer Information

Exchange: NSC
CEO: Charles S. Ryan
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Neurotrope Inc is a biopharmaceutical company. The company is principally focused on developing a product platform based on a drug candidate called bryostatin for the treatment of Alzheimer's disease ("AD"), which is in the clinical testing stage. It is also developing bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C, which are in pre-clinical testing.

Contact Information

Website: www.neurotrope.com
Email: rweinstein@neurotrope.com
Main Phone: +1 973 242-0005
Address: 1185 Avenue of the Americas
Address 2: 3rd Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10036

Issuer Information

Exchange: NSC
CEO: Charles S. Ryan
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 1.13 $ -0.13 (-10.32%)
Last Price 1.13 Change $ -0.13 Change % -10.32 Tick N/A
Bid 1.14 Bid Size 5,100.00 Ask 1.21 Ask Size 500.00
Open 1.28 High 1.28 Low 1.07 Prev Close 1.26
Last Trade Volume 401,367 52 Wk Hi 6.00 52 Wk Low 0.63
Market Cap 26.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 23,674,089.00 EPS (TTM) -0.93 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16 16 16 16
Low Target Price Estimate 15 15 15 15
Mean Target Price Estimate 15.5 15.5 15.5 15.5
Standard Deviation 0.71 0.71 0.71 0.71
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 05/17/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 1 1 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1